Well over two thirds of non-prescription brand sales are derived from reimbursable products available on a doctor's prescription. Non-prescription pharmaceuticals account for about a quarter of prescription sales in France and a third of the total pharmaceutical market. They are, therefore, an important part of the industry. Over half of French c ompanies have reimbursable non-prescription products in their portfolios and roughly half of these are reliant upon them for sizeable parts of their profit streams.
Recent changes to the French reimbursement system, combined with a diminishing trend in prescriptions for non-prescription bound pharmaceuticals, will have an effect on manufacturers' marketing strategies.
This strategic analysis not only explores the main factors influencing the French market in depth, it also provides scenarios for the next 5 years.
PUBLISHED: JANUARY 2000
REF: BS1109E
PAGES: 260+
PRICE: £1,295/$2,710/¥311,000
CHAPTER 1
CHALLENGES TO THE FRENCH MARKET FOR NON-PRESCRIPTION PHARMACEUTICALS
1. Introduction
2. Sales Split of the Total Non-Prescription Bound Market in France
3. Sales Split of the Total OTC Market in France
4. Category Evolution, 1991 - 1998
5. Classification of Medicines in France
5.1 Directive 92/26/EEC - Classification of Medicines
5.2 Legal Definition of Non-Prescription in France
6. Advertising Regulations
7. Use of Trademarks for Medicinal Products
8. The Prescription Sector
8.1 Government Price Controls and Reimbursement Systems
8.2 Price Control
8.3 Reimbursement Bands
8.4 Positive List of Products for Reimbursement
9. Controls on Healthcare Expenditure
9.1 Controls on Pharmaceutical Expenditure
9.2 Supply Side Controls
9.2.1 Pricing
9.2.2 Reimbursement
9.2.3 Promotion
9.3.1 Consumption Controls
9.3.2 Patients
9.3.3 Distributors
10. Healthcare Reforms 1993-1998
11. New Reforms Announced in 1999
12. Generics
13. Consumer Behaviour
13.1. Doctor Consultation for Minor Ailments
14. Generic Segmentation of Consumers
15. Structure of the French Non-Prescription Bound Market
16. Types of Non-Prescription Product
17. The Advertising and Promotion Environment
18. Media - Consumer Advertising in France
19. Attractiveness of the French Non-Prescription Market
20. Attractiveness of the French OTC Market 1999
20.1 Conclusions of the Attractiveness of the French Non-Prescription Market
21. Outlook for the French Non-Prescription Pharmaceuticals Market to 2004
22. Category Gains and Losses to 2004
22.1 Two Track Market for Non-Prescription Pharmaceuticals
23. Forecasts � Non-Prescription Pharmaceuticals France 1998-2004
List of Tables
Table 1
France Total Market Market Growth Indices (Value), 1991 - 1997
Table 2
Numbers Claiming to Visit a Doctor for Minor Ailments (Percentage of Sufferers)
Table 3
Analysis of Consumer Segments by Source of Treatment:% of Adult Populations Suffering Minor
Ailments
Table 4
Estimates of Self-Medication: % of Sufferers Claiming Self-Medication in France
Table 5
Public Advertising: Share of Expenditure by Principal Product Categories in France
List of Graphs
Graph 1:
Development of the Total Non-Prescription Bound Market, 1987-1999
Graph 2:
Total Non-Prescription Bound Sales in France Split by Major Category (Value), 1999
Graph 3:
Total OTC Sales in France Split by Major Category (Value), 1999
Graph 4:
Pharmacy Wholesale Purchases compared to Pharmatrend.
Graph 5:
Split of Consumer Advertising by Media in France 1998
Graph 6:
Attractiveness of the French Non Prescription Market, 1999
Graph 7:
Attractiveness of the French OTC Sector 1999
Graph 8:
Estimated Gains and Losses, Major Non-Rx Categories, 1998-2004 ($ Millions)
Graph 9:
$ Indexed Growth of Non-Prescription Pharmaceuticals - France 1999 - 2005
Graph 10:
Forecast � The Total Non-Prescription Market France 1998-2004 ($ Millions)
CHAPTER 2
UPPER RESPIRATORY TRACT REMEDIES - FRANCE
1. Sales of Cough, Cold, Hayfever and Pharyngeal Remedies as a Share of the Total Market
1.1 Retail Sales
2. Sales Split of Cough, Cold, Hayfever and Pharyngeal Remedies Total Non-Prescription
Bound Upper Respiratory Tract Market France
3. Advertising
4. Rx to OTC
5. Sales of Cough Remedies
5.1 Retail Sales
6. Segmentation
6.1 Dosage Form
7. Key Manufacturers in the Cough Remedy Market
8. Key Brands in the Cough Remedy Market
9. Marketing
9.1 Distribution
10. Advertising
11. Forecasts
12. Sales of Cold and Flu Remedies
12.1 Retail Sales
13. Segmentation
13.1 Dosage Form
14. Key Manufacturers in the Cold and Flu Market
15. Key Brands in the Cold and Flu Market
16. Marketing
16.1 Distribution
16.2 Innovation
17. Advertising
18. Brand Marketing
19. Forecast for Cold and Flu Remedies
20. Sales of Nasal Decongestants
20.1 Retail Sales
21. Structure of Sales
22. Segmentation
22.1 Dosage Form
23. Key Manufacturers in the Nasal Decongestant Market
24. Key Brands in the Nasal Decongestants Market
25. Marketing
25.1 Distribution
26. Advertising
27. Brand Marketing
28. Forecast for Nasal Decongestants
29. Sales of Inhalants
29.1 Retail Sales
30. Structure of Sales
31. Segmentation
31.1 Dosage Form
32. Key Manufacturers in the Inhalants Market
33. Key Brands in the Inhalants Market
34. Advertising
35. Brand Marketing
36. Forecast for Inhalants
37. Sales of Hayfever Remedies
37.1 Retail Sales
38. Segmentation
39. Key Manufacturers in the Hayfever Market
40. Key Brands in the Hayfever Market
41. Marketing
41.1 Distribution
41.2 Terfenadine
42. Advertising
43. Forecast for Hayfever Remedies
44. Sales of Sore Throat Remedies
44.1 Retail Sales
45. Structure of Sales
46. Segmentation
47. Key Manufacturers in the Sore Throat Market
48. Key Brands in the Sore Throat Market
49. Marketing
49.1 Distribution
50. Advertising
51. Brand Marketing
52. Forecast for Sore Throat Remedies
53. Forecast for the Cough, Cold, Hayfever and Pharyngeal Remedies Market
List of Tables
Table 1
Rx to OTC Switch List France
Table 2
Cough Remedies Key Manufacturers' Share of Total Non-prescription Bound Market
Table 3
Cough remedies Key Brands' Share of Total Non-prescription Bound and OTC Self-medication Market �..
Table 4
Cold & Flu Remedies Key Manufacturers' Share of Non-prescription Bound Market (% Value) 1998..
Table 5
Cold and Flu Remedies Key Brands' Share of the Total Non-prescription Bound and OTC
Self-medication Market
Table 6
Topical Nasal Decongestants Key Manufacturers' Share of Non-prescription Bound Market
Table 7
Nasal Decongestants Key Brands' Share of the Total Non-prescription Bound and OTC Self-
Medication Market
Table 8
Inhalants Key Manufacturers' Share of Non-prescription Bound Market
Table 9
Inhalants
Table 10
Hayfever Remedies Key Manufacturers' Share of Non-prescription Bound Market (% Value) 1998
Table 11
Hayfever Remedies Key Brands' Share of the Total Non-prescription Bound and OTC Self-
Medication Market (% Value) 1998
Table 12
Sore Throat Remedies Key Manufacturers' Share of Non-prescription Bound Market (% Value)1998 .
Table 13
Sore Throat Remedies Key Brands' Share of the Total Non-prescription Bound (% Value) 1998
List of Graphs
Graph 1:
Development of Cough, Cold, Hayfever and Pharyngeal Remedies Market 1989-1998
Graph 2:
Total Non-Prescription Bound Sales of Cough, Cold, Hayfever and Pharyngeal Remedies - Split by
Major Category (Value) 1998
Graph 3:
Total OTC Sales of Cough, Cold, Hayfever and Pharyngeal Remedies - Split by Major Category
(Value) 1998
Graph 4:
Advertising Expenditure Split by Medium
Graph 5:
Advertising Expenditure Split by Subcategory
Graph 6:
Development of Cough Remedies Market 1989-1998
Graph 7:
Advertising Share of Voice by Major Brand
Graph 8:
Forecast Development of Cough Remedies Market 1998-2004
Graph 9:
Development of Cold and Flu Remedies Market 1989-1998
Graph 10:
Advertising Share of Voice by Major Brand
Graph 11:
Forecast Development of Cold and Flu Remedies Market 1998-2004
Graph 12:
Development of Nasal Decongestants Market 1989-1998
Graph 13:
Advertising Share of Voice by Major Brand
Graph 14:
Forecast Development of Nasal Decongestants Market 1998-2004
Graph 15:
Development of Inhalants Market 1989-1998
Graph 16:
Forecast Development of Inhalants Market 1998-2004
Graph 17:
Development of Hayfever Remedies Market 1989-1998
Graph 18:
Forecast Development of Hayfever Remedies Market 1998-2004
Graph 19:
Development of Sore Throat Remedies Market 1989-1998.
Graph 20:
Advertising Share of Voice by Major Brand
Graph 21:
Forecast Development of Sore Throat Remedies Market 1998-2004
Graph 22:
Forecast Development of Cough, Cold, Hayfever and Pharyngeal Remedies Market 1998-2004
CHAPTER 3
GASTRO-INTESTINAL MARKET - FRANCE
1. Sales of Gastro-Intestinal Products as a Share of the Total Market
1.1 Retail Sales
2. Sales Split of Gastro-Intestinal Market
Share of the Total Non-Prescription Bound Gastro Intestinal Market
3. Advertising
4. Prospects 1999 - 2004
5. Sales of Digestive Remedies
5.1 Retail Sales
6. Sales Split in the Digestive Remedies Market
7. Key Manufacturers in the Antacids Market
8. Key Brands in the Antacids Market
9. Key Brands in the Digestive Remedies Market
9.1 Key Brands in the Antiflatulants Market
10. Marketing
10.1 Distribution
10.2 Innovation
11. Advertising
12. Brand Marketing
13. H2 OTCs
14. Forecasts
15. Laxatives
15.1 Retail Sales
16. Key Manufacturers in the Laxatives Market
17. Key Brands in the Laxatives Market
18. Marketing
18.1 Distribution
19. Brand Marketing
19.1 Advertising
20. Forecast for Laxatives
21. Sales of Antidiarrhoeals
21.1 Retail Sales
22. Key Manufacturers in the Antidiarrhoeals Market
23. Key Brands in the Antidiarrhoeals Market
24. Advertising
25. Distribution
26. Forecast for Antidiarrhoeals Market
27. Forecast for Gastro-Intestinal Products
List of Tables
Table 1
Digestive Remedies Key Manufacturers' Share of Total Non-Prescription Bound Market
(% Value) 1998
Table 2
Antacids Key Brands' Share of Total Non-Prescription Bound
and OTC Self-Medication Market for Digestive Remedies (% Value) 1998
Table 3
Key Brands' Share of Total Non-Prescription Bound and OTC Self-Medication Market
Digestive Remedies (% Value) 1998
Table 4
Key Brands' Share of the Antiflatulant Market and OTC Self-Medication (% Value) 1998
Table 5
Laxatives Key Manufacturers' Share of Non-Prescription Bound Market (% Value) 1998
Table 6
Laxatives Key Brands' Share of the Total Non-Prescription Bound Market (% Value) 1998
Table 7
Antidiarrhoeals Key Manufacturers' Share of Non-Prescription Bound Market (% Value) 1998
Table 8
Antidiarrhoeals Key Brands' Share of Non-Prescription Bound Market (% Value) 1999 Compared to
1991
List of Graphs
Graph 1:
Development of Gastro-Intestinal Market 1989-1998
Graph 2:
Total Non-Prescription Bound Sales of Gastro-Intestinal Products - Split by
Graph 3:
Total OTC Sales of Gastro-Intestinal Products - Split by Major Category (Value) 1998
Graph 4:
Advertising Expenditure Split by Medium
Graph 5:
Advertising Expenditure Split by Subcategory
Graph 6:
Development of Digestive Remedies Market 1989-1998
Graph 7:
Sales Split of the Digestive Remedies Market 1998
Graph 8:
Advertising Share of Voice by Major Brand
Graph 9:
Forecast Development of Digestive Remedies Market 1998 - 2004
Graph 10:
Development of Laxatives Market 1989-1998
Graph 11:
Advertising Expenditure by Medium
Graph 12:
Advertising Share of Voice
Graph 13:
Forecast Development of Laxatives Market 1998-2004
Graph 14:
Development of Antidiarrhoeals Market 1989-1998
Graph 15:
Forecast Development of Antidiarrhoeals Market 1998-2004
Graph 16:
Forecast Development of Gastro-Intestinal Market 1998-2004
CHAPTER 4
VITAMINS, MINERALS AND SUPPLEMENTS - FRANCE
1. Sales of Multivitamins, Minerals and Supplements as a Share of the Total Market
1.1 Retail Sales
2. Sales Split of the Vitamins, Minerals and Supplements Market
3. Advertising
3.1 Vitamins
3.2 Supplements
4. Sales of Multivitamins
4.1 Retail Sales
5. Key Manufacturers in the Multivitamins Market
6. Key Brands in the Multivitamins Market
7. Brand Marketing
8. Prospects
9. Forecasts 1998 - 2004
10. Sales of B Vitamins
10.1 Retail Sales
11. Key Manufacturers in the B Vitamins Market
12. Key Brands in the B Vitamins Market
13. Marketing
14. Advertising
15. Forecast for Vitamin B
16. Sales of Vitamin C
16.1 Retail Sales
17. Key Manufacturers in the Vitamin C Market
18. Key Brands in the Vitamin C Market
19. The Non Pharmacy Market
20. Brand Marketing
21. Prospects
22. Forecast for Vitamin C
23. Sales of Minerals
23.1 Retail Sales
24. Sales Split of the Minerals Market
25. Key Brands in the Minerals Market
26. Brand Marketing
27. Forecast for Minerals
28. Forecast for the Vitamins, Minerals and Supplements Market
List of Tables
Table 1
Multivitamins Key Manufacturers' Share of Total Non-Prescription Bound Market (%Value)1998
Table 2
Multivitamins -Key Brands' Share of Total Non-Prescription Bound\Market (% Value) 1998
Table 3
Major Brand Advertisers Multivitamins France
Table 4
B Vitamins - Key Manufacturers' Share of Non-Prescription Bound Market (% Value) 1998
Table 5
B Vitamins Key Brands' Share of the Non-Prescription Bound Market (% Value) 1998
Table 6
Vitamin C - Key Manufacturers' Share of Non-Prescription Bound Market (% Value) 1998
Table 7
Vitamin C Key Brands' Share of the Non-Prescription Bound Market (% Value) 1998
Table 8
Minerals - Magnesium Key Brands' Share of the Non-Prescription Bound Market (% Value) 1998
Table 9
Minerals - Calcium Key Brands' Share of the Non-Prescription Bound Market (% Value) 1998
Table 10
Minerals - Iron Key Brands' Share of the Non-Prescription Bound Market (% Value) 1998
List of Graphs
Graph 1:
Development of the Vitamins, Minerals and Supplements Market 1989-1998
Graph 2:
Total Non-Prescription Bound Sales of the Vitamins, Minerals and Supplements Market - Split by
Major Category (Value) 1998
Graph 3:
Advertising Expenditure by Medium
Graph 4:
Advertising Share of Voice by Major Brand - Vitamins
Graph 5:
Advertising Share of Voice by Major Brand - Other Supplements
Graph 6:
Development of Multivitamins Market 1989-1998 (Pharmacy only)
Graph 7:
Forecast Development of Multivitamins Market 1998 � 2004
Graph 8:
Development of Vtamin B Market 1989 - 1998
Graph 9:
Forecast Development of Vitamin B Market 1998 - 2004
Graph 10:
Development of Vitamin C Market 1989 - 1998
Graph 11:
Forecast Development of Vitamin C Market 1998 - 2004
Graph 12:
Development of Minerals Market 1989 - 1998
Graph 13:
Total Non-Prescription Bound Sales of Minerals Split by Category 1998
Graph 15:
Forecast Development of the Vitamins, Minerals and Supplements Market 1998 � 2004
CHAPTER 5
PAIN RELIEF MARKET � FRANCE
1. Sales of Pain Relief Products as a Share of the Total Market
1.1 Retail Sales
2. Sales Split of the Pain Relief Market
3. Rx to OTC
4. Sales of Oral Analgesics
4.1 Retail Sales
5. Key Manufacturers in the Oral Analgesics Market
6. Key Brands in the Oral Analgesics Market
7. Marketing
7.1 Distribution
8. Advertising
9. Innovation
10. Forecasts
11. Sales of Topical Analgesics
11.1 Retail Sales
12. Key Manufacturers in the Topical Analgesics Market
13. Key Brands in the Topical Analgesics Market
14. Mass Market Brands
15. Marketing
15.1 Distribution
16. Advertising
17. Innovation
18. Forecast for Topical Analgesics
19. Forecast for the Pain Relief Market
List of Tables
Table 1
Status of Key Substances
Table 2
Oral Analgesics Key Manufacturers' Share of Total Non-Prescription Bound Market
(% Value) 1992-1998
Table 3
Oral Analgesics Key Brands' Share of Total Non-Prescription Bound Market (% Value) 1992-1998
Table 4
Topical Analgesics Key Manufacturers' Share of Non-Prescription Bound Market (% Value) 1998
Table 5
Topical Analgesics Key Brands' Share of the Total Non-Prescription Bound (% Value) 1998
Table 6
Leading Mass Market Brands, Topical Pain Relief
List of Graphs
Graph 1:
Development of Pain Relief Market 1989-1999
Graph 2:
Total Non-Prescription Bound Sales of Pain Relief Products - Split by Major Category (Value) 1998
Graph 3:
Total OTC Sales of Pain Relief Products - Split by Major Category (Value) 1998
Graph 4:
Development of Oral Analgesics Market 1989-1998
Graph 5:
Split of Advertising Expenditure by Medium
Graph 6:
Share of Voice by Brand
Graph 7:
Forecast Development of Oral Analgesics Market 1998 - 2004
Graph 8:
Development of Topical Analgesics Market 1989-1998
Graph 9:
Forecast Development of Topical Analgesics Market 1998 - 2004
Graph 10:
Forecast Development of Pain Relief Market 1998 - 2004
CHAPTER 6
SKIN CARE MARKET � FRANCE
1. Sales of Dermatological Products in France
1.1 Retail Sales
2. Dermatalogical Market Split by Category
3. Skin Irritation Products in France
4. Leading OTC Brands and Manufacturers in the French Skin Irritation Market
5. Advertising
6. Innovation
7. Forecasts for the French Skin Irritation Market
8. Acne Treatments in France
9. Forecasts for the Pharmacy Acne Market
10. Sales of Antifungal Products
11. Anti-fungal Market Split by Active Agent
12. Antifungal Products: Main Competitors
12.1 Brand Marketing
13. Forecast for the Antifungal Market in France
14. Sales of Gynaecological Antimycotics in France
15. The Gynaecological Anti-fungals Market Split by Active Agents
16. Gynaecological Antifungals: Main Competitors
16.1 Brand Marketing
17. Market Forecasts for Gynaecological Antimycotics in France
18. Antiseptics
19. Antiseptics: Key Competitors
20. Market Forecasts for Antiseptics and Wound Healing Products
21. Wound Healing Products
22. Wound Healing Products: Key Competitors
22.1 Marketing Investment
23. Cold Sore Products
24. Cold Sore Products: Key Competitors
24.1 Marketing Investment
25. Forecasts for Cold Sore Treatments inFrance
26. Sales of Skin Protector Products in France
27. Skin Protector Products: Key Competitors
27.1 Brand Marketing
28. Forecasts for Skin Protector Products in France, 1998 � 2003
29. Market Forecasts for Dermatological Products in France
List of Tables
Table 1
Leading Brands and Manufacturers in the Skin Irritation Market, 1997
Table 2
Leading Manufacturers and Brands in the Antifungal Market, 1998
Table 3
Leading Brands and Manufacturers of Antiseptic Products, 1998
Table 4
Cold Sore Products Market Share by Value in France, 1998
Table 5
Leading Skin Protective Products: Market Share by Value in France, 1998
List of Graphs
Graph 1:
Development of the Dermatology Market, 1991-1998
Graph 2:
Breakdown of the French Non-prescription Dermatological Market by Sub Category, 1998
Graph 3:
Skin Irritation Products in France, 1993 � 1998
Graph 4:
Growth Estimates for the French Skin Irritation Market, 1998 - 2003
Graph 5:
Non-Prescription Acne Products in France: Pharmacy Market 1993 - 1998
Graph 6:
The Market for Antifungals in France, 1993 � 1998
Graph 7:
Anti-fungal Market Split by Active Agent, 1998
Graph 8:
Sales Estimates for the Non-prescription Antifungals Market in France 1998 � 2003
Graph 9:
Non-Prescription Gynaecological Antimycotics in France 1993 - 1998
Graph 10:
Gynaecological Anti-fungals Market Split by Active Agent, 1998
Graph 11:
Sales Estimates for Gynaecological Antifungal Products in France 1998 - 2003
Graph 12:
Market Development of Antiseptics in France, 1993 - 1998
Graph 13:
Pharmacy Sales Estimates for Antiseptics in France, 1998 - 2003
Graph 14:
Market Development of Wound Healing Products in France, 1993 - 1998
Graph 15:
Sales Estimates for Wound Healing Products in France, 1998 - 2003
Graph 16:
Cold Sore Treatments in France, 1997 and 1998
Graph 17:
Sales Estimates for Non-Prescription Cold Sore Products in France, 1998 � 2003
Graph 18:
Skin Protector Products and Emollients in France, 1993 � 1998
Graph 19:
Sales Estimates for Skin Protector Products in France, 1998 � 2003
Graph 20:
Sales Estimates for Total Non-prescription Dermatological Products Market in France, 1998 - 2003
CHAPTER 7
CIRCULATORY PRODUCTS - FRANCE
1. Sales of Circulatory Products as a Share of the Total Market
1.1 Retail Sales
2. Sales Split of the French Circulatory Products Market
3. Ginkgo Biloba
3.1 Ginkgo Biloba � Major Brands
3.2 Brand Marketing
3.3 Forecasts for Ginkgo Biloba Products
4. Varicose Vein Treatments Market
4.1 Systemic Varicose Vein Treatments
4.2 The Major Brands in the Systemic Varicose Vein Treatments Market
4.3 Brand Marketing
4.4 Sales Forecasts Systemic Varicose Vein Treatments
4.5 Topical Varicose Vein Treatments
4.6 Leading Brands of Topical Varicose Vein Treatments
4.7 Brand Marketing Topical Varicose Vein Treatments
4.8 Forecasts for Topical Varicose Vein Treatments
4.9 Forecast for the Total Varicose Vein Treatments Market
5. Anti-Haemorrhoidal Products Market
6. Leading Brands of Anti-Haemorrhoidal Products
7. Brand Marketing
8. Forecast for Anti haemorrhoidal Products
9. Heart Attack Prevention
10. Leading Brands of Heart Attack Prevention Products
11. Brand Marketing
12. Forecasts for Heart Attack Prevention Products
13. The Circulation Regulators Market
14. Leading Brands � Circulation Regulators
15. Brand Marketing
16. Forecast Circulation Regulators
17 Forecasts for Circulatory Products
List of Tables
Table 1
Ginkgo Biloba Major Brand Market Share by Value 1998
Table 2
Systemic Antivaricose Vein Products Market Share by Value 1998
Table 3
Topical Antivaricose Vein Products Market Share by Value 1998
Table 4
Anti-Haemorroidal Products' Market Share by Value
Table 5
Heart Attack Prevention Market Share by Value
Table 6
Leading Circulation Regulator Brands % Share of Market by Value 1998
List of Graphs
Graph 1:
Development of the Circulatory Products Market, 1993-1998
Graph 2:
Total Circulatory Products Split by Major Category and % Value, 1998
Graph 3:
Sales Development Ginkgo Biloba 1995 � 1998($000s)
Graph 4:
Forecasts Ginkgo Biloba Products 1998-2004($ million)
Graph 5:
Sales Development Total Varicose Vein Treatments (Systemic and Topical) 1993 � 1998 ($ Millions)
Graph 6:
Systemic Varicose Vein Treatments 1993 � 1998 ($ Millions)
Graph 7:
Forecasts Systemic Varicose Vein Treatments 1998-2004
Graph 8:
Sales Development Topical Varicose Vein Treatments 1993-1998 ($ Millions)
Graph 9:
Forecasts � Topical Varicose Vein Treatments 1998 � 2004 ($ millions)
Graph 10:
Forecasts � Total Varicose Vein Treatments 1998 � 2004 ($ Millions)
Graph 11:
Development of the Anti-haemorrhoids Market 1993-1998
Graph 12:
Forecast � Anti haemorrhoids Market 1998 � 2004 ($ Millions)
Graph 13:
Development of Heart Attack Prevention Products 1993-1998 ($ Millions)
Graph 14:
Forecast � Heart Attack Prevention Products 1998-2004 ($ Millions)
Graph 15:
Sales Development of Circulation Regulators � 1993-1998
Graph 16:
Forecast Sales for Non Prescription Circulation Regulators 1998- 2004 ($ Millions)
Graph 17:
Forecast Sales for Non-Prescription Circulatory Products 1998 �2004 ($ Millions)
CHAPTER 8
BRANDS AND INNOVATION
IN THE FRENCH NON PRESCRIPTION MARKET.
1. Brand Sizes
1.2 Brand Values by Type
2. OTC Consumption
3. Age of Brands In France
4. Rx to OTC Switches
4.1 H2 Antagonists
4.2 Hydrocortisone
4.3 Topical Aciclovir
4.5 Levonorgestrel
4.6 Nifuroxazide
4.7 Oral Ketoprofen
5. Attitudes of Doctors and Pharmacists to Rx to OTC Switches
6. Winners and Losers in New Brand Launches in France
6.1 Leading Innovators in France 1992-1997
6.2 Successful New Consumer Brands in France
6.3 Success formula for New Brands in France
7. Case Studies in New Brand Marketing inFrance
7.1 Activir
7.1.1 The Product Concept
7.1.2 The Outcome of the Activir Launch
7.2 Dolirhume
7.2.1 Branding
7.2.2.Launch Strategy
7.2.3.Outcome of the Launch
7.3 Bifix
7.3.1.Outcome of the Bifix Launch
7.4 Nurofen/Nureflex
7.4.1.Outcome of the Nurofen Consumer Launch
7.4.2.The success factors in the Nurofen/Nureflex strategy
List of Tables
Table 1
Top 10 Non- Prescription Products France $ Values (est) 1998
Table 2
Top 10 Semi- Ethical Brands OTC Consumption $ Values(est) 1998($ millions)
Table 3
Top 10 OTC Brands France- $ Values(est) 1998($ millions)
Table 4
Attitudes of Doctors Compared to Pharmacists to Recent 'switches' in France % of Doctors and Pharmacists in Favour
Table 5
Leading Innovators in France Brands Launched 1992-1997
Table 6
New Non- prescription Products � France
List of Graphs
Graph 1:
French Non-Prescription Market � % Share by Brand Size ($ Millions)
Graph 2:
French Non-Prescription Market � Cumulative % Share � Leading 160 Brands
Graph 3:
% of Brands Over 10 Years Old in France by Category
Graph 4:
% of Successful New Products Launched 1992-1997
CHAPTER 9
DISTRIBUTION CHANNEL SYSTEMS
FOR NON-PRESCRIPTION PHARMACEUTICALS
1. Distribution Channel Systems for Non-Prescription Pharmaceuticals
2. The Retail Pharmacy Sector
3. Pharmacy Density by Region
3.1 Structure of Retail Pharmacy Economics
4. Prices and Margins
4.1 Cash Flow
5. Consumer Attitudes Towards Pharmacists
6. Presentation of Non-Prescription Bound Brands
7. Non-Pharmacy Channels
7.2 Health Centres
8. Non-Pharmacy Distribution in France
9. Grocery Market for Multivitamins
9.1 Movement to Non-Pharmacy
10. Pharmaceutical Wholesalers
11. Manufacturer Strategies in the Pharmacy Sector
12. Pharmacy and Non-Pharmacy Strategies
13. Distribution in France: Change Drivers for the Future
13.1 Retailer Development
13.2 Wholesalers
List of Tables
Table 1
Pharmacy Demographics According to Population, 1996
Table 2
Distribution of Retail Pharmacies by Region in France.
Table 3
Pharmaceutical Wholesalers' Share of Market and Distribution 1998
Table 4
Manufacturers % Sales Direct to Retail Pharmacies
List of Graphs
Graph 1:
Number of Retail Pharmacies in France 1962 - 1998
Graph 2:
Pharmacy Sales by Source
Graph 3:
% Consumers Seeking Pharmacist's Advice, 1994
Graph 4:
Consumer Beliefs in Pharmacist Knowledge about Medicines Compared to Doctors
Graph 5:
Presentation Preferences: Non-Prescription Bound Medicines
Graph 6:
Presentation Preferences: Non-Prescription Bound Medicines by Age of Consumer
List of Figures
Figure 1:
Outline Structure of OTC Pharmaceutical Distribution in France
CHAPTER 10
IMPACT OF DE-REIMBURSEMENT ON THE MAIN COMPETITORS
IN THE FRENCH NON-PRESCRIPTION PHARMACEUTICAL MARKET
1. The Effects of Change on France's Major Non-Prescription Companies
1.1 The Non-Prescription Market
2. Aventis
3. Sanofi-Synthélabo
4. Pierre Fabre
5. Servier
6. Beaufour Ipsen
7. Bristol Myers Squibb
8. Roche Nicholas
9. Companies with Strengths in Self-Medication
9.1 Warner Lambert
9.2 Monot/Lipha (E Merck AG)
9.3 SmithKline Beecham
9.4 Boiron
10. Conclusions � the Impact of De-reimbursement on the Major Competitors in the Market
11. Scenarios for Vulnerable Product Categories in a Post-Dereimbursement Environment
11.1 Doctors' Attitudes to Self-Medication
11.2 Consumer Usage Purchasing Behaviour
11.3 Distribution Channel Weaknesses
11.4 Negative Propaganda from the French Authorities
12. The Effects of De-reimbursement on The Non-Prescription Pharmaceutical Sector
13. Post De-reimbursement Strategies Anti-Asthenics, France
13.1 Asta Medica
13.2 Chefaro-Ardeval (Akzo Nobel)
13.3 Servier
13.4 Summary of Gains and Losses: Antiasthenics Pre- and Post- De-reimbursement
13.5. Conclusions Post De-reimbursement Strategies for Anti-asthenics
14. Non-Prescription Pharmaceuticals: New Strategies for the Future
15. Conclusion
List of Tables
Table 1
Non-Prescription Market Leading Companies % Share by Value
Table 2
Aventis Non-Prescription Portfolio 1999
Table 3
Rh�ne Poulenc Rorer Key Non-Prescription Brands, France
Table 4
Sanofi-Synth�labo Non-Prescription Portfolio 1999
Table 5
Sanofi Synth�labo Key Non-Prescription Brands � France 1998
Table 6
Pierre Fabre Non�Prescription Portfolio 1999
Table 7
Pierre Fabre � Key Non-Prescription Brands � France
Table 8
Servier Non�Prescription Portfolio 1999
Table 9
Servier Key Non-Prescription Brands- France
Table 10
Beaufour Ipsen Non�Prescription Portfolio 1999
Table 11
Bristol Myers Squibb Non�Prescription Portfolio 1999
Table 12
Bristol Myers Squibb � Key Non-Prescription Brands, France
Table 13
Roche Nicholas - Non�Prescription Portfolio 1999
Table 14
Roche Nicholas' Key Non-Prescription Brands
Table 15
Leading Companies �OTC Pharmaceuticals, France
Table 16
Warner Lambert Key Non-Prescription Brands � France
Table 17
Lipha/Monot and Pharminter (Lipha/Merck)
Table 18
Smithkline Beecham Key Non-Prescription Brands � France
List of Graphs
Graph 1:
Sales of Leading Anti-Asthenics Pre- and Post Delisting of Reimbursement 1990-1992
Graph 2:
Sargenor Sales Values (MSPP $ Million) 1990 - 1998
Graph 3:
Guronsan Sales Values ($ Millions 1990 to 1998)
Graph 4:
Arcalion Sales ($ Millions) 1990-1998
Graph 5:
Annual Sales Losses of Leading Anti-Asthenics
Graph 6:
Scenarios of Vulnerable Major Categories in a Post De-reimbursement Environment, based on the History of Anti-Asthenics 1998-2004 ($ Million)
© PJB Publications Ltd. 2001
All rights reserved.